PERTUZUMAB

UNII:	K16AIQ8CTM
Formula:
Preferred Substance Name:	PERTUZUMAB

380610-27-5
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
PERJETA
PERTUZUMAB (GENETICAL RECOMBINATION)
PERTUZUMAB [INN]
PERTUZUMAB [JAN]
PERTUZUMAB [MART.]
PERTUZUMAB [MI]
PERTUZUMAB [PURPLE BOOK CDER]
PERTUZUMAB [USAN]
PERTUZUMAB [VANDF]
PERTUZUMAB [WHO-DD]
PERTUZUMAB BIOSIMILAR (CSPC PHARMA)
PERTUZUMAB-ZZXF
PHESGO COMPONENT PERTUZUMAB
RG-1273
RHUMAB 2C4
RHUMAB2C4
RHUMAB-2C4
SYSA1901
SYSA-1901
SYSA-1901 (PERTUZUMAB BIOSIMILAR)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PERTUZUMAB

Synonyms and Mappings

Resources